Johnson & Johnson (JNJ)
273.05
+2.81
(+1.04%)
USD |
NYSE |
Aug 24, 16:00
273.40
+0.35
(+0.13%)
After-Hours: 19:20
Johnson & Johnson Price to Book Value : 7.739 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 7.659 |
| August 20, 2026 | 7.578 |
| August 19, 2026 | 7.749 |
| August 18, 2026 | 7.684 |
| August 17, 2026 | 7.436 |
| August 14, 2026 | 7.379 |
| August 13, 2026 | 7.428 |
| August 12, 2026 | 7.393 |
| August 11, 2026 | 7.363 |
| August 10, 2026 | 7.420 |
| August 07, 2026 | 7.347 |
| August 06, 2026 | 7.283 |
| August 05, 2026 | 7.301 |
| August 04, 2026 | 7.225 |
| August 03, 2026 | 7.210 |
| July 31, 2026 | 7.265 |
| July 30, 2026 | 7.250 |
| July 29, 2026 | 7.526 |
| July 28, 2026 | 7.560 |
| July 27, 2026 | 7.538 |
| July 24, 2026 | 7.465 |
| July 23, 2026 | 7.348 |
| July 22, 2026 | 7.245 |
| July 21, 2026 | 7.103 |
| July 20, 2026 | 7.052 |
| Date | Value |
|---|---|
| July 17, 2026 | 7.172 |
| July 16, 2026 | 7.085 |
| July 15, 2026 | 7.001 |
| July 14, 2026 | 7.195 |
| July 13, 2026 | 7.306 |
| July 10, 2026 | 7.283 |
| July 09, 2026 | 7.343 |
| July 08, 2026 | 7.465 |
| July 07, 2026 | 7.574 |
| July 06, 2026 | 7.350 |
| July 02, 2026 | 7.455 |
| July 01, 2026 | 7.198 |
| June 30, 2026 | 7.198 |
| June 29, 2026 | 7.663 |
| June 26, 2026 | 7.549 |
| June 25, 2026 | 7.259 |
| June 24, 2026 | 7.144 |
| June 23, 2026 | 7.087 |
| June 22, 2026 | 6.856 |
| June 18, 2026 | 6.770 |
| June 17, 2026 | 6.942 |
| June 16, 2026 | 6.971 |
| June 15, 2026 | 6.986 |
| June 12, 2026 | 7.140 |
| June 11, 2026 | 7.065 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 34.67 |
| Merck & Co., Inc. | 8.873 |
| Pfizer Inc. | 1.872 |
| Bristol Myers Squibb Co. | 6.161 |
| Liquidia Corp. | 32.09 |
Price to Book Value Related Metrics
| PE Ratio | 31.65 |
| PS Ratio | 6.798 |
| Price to Free Cash Flow | 29.44 |
| Price | 273.05 |
| Earnings Yield | 3.16% |
| Market Cap | 657.57B |
| Operating PE Ratio | 25.19 |
| Normalized PE Ratio | 28.81 |